263 reports of this reaction
1.7% of all ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE reports
#12 most reported adverse reaction
RENAL FAILURE is the #12 most commonly reported adverse reaction for ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, manufactured by Haleon US Holdings LLC. There are 263 FDA adverse event reports linking ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE to RENAL FAILURE. This represents approximately 1.7% of all 15,305 adverse event reports for this drug.
Patients taking ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL FAILURE is a less commonly reported adverse event for ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, but still significant enough to appear in the safety profile.
In addition to renal failure, the following adverse reactions have been reported for ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE:
The following drugs have also been linked to renal failure in FDA adverse event reports:
RENAL FAILURE has been reported as an adverse event in 263 FDA reports for ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL FAILURE accounts for approximately 1.7% of all adverse event reports for ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, making it a notable side effect.
If you experience renal failure while taking ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.